|
FoamiconDrug - Foamicon The trade name of the product as shown on the labeling.
Dosage -
TABLET, CHEWABLE; ORAL
Active Ingredient(s) -
Aluminum Hydroxide; Magnesium Trisilicate
Strength -
80MG;20MG
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
072687
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jun 28, 1989
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Consumer Health Inc
Foamicon
Muse 0.25mg Suppository; Urethral
Muse 0.5mg Suppository; Urethral Muse 1mg Suppository; Urethral Rautensin 2mg Tablet; Oral Rauwiloid 2mg Tablet; Oral Hexalen 50mg Capsule; Oral Aluminum Hydroxide And Magnesium Trisilicate 80mg;20mg Tablet, Chewable; Oral Foamcoat 80mg;20mg Tablet, Chewable; Oral Foamicon 80mg;20mg Tablet, Chewable; Oral Muse 0.125mg Suppository; Urethral NewDrugInformation |